Phosphatase PTP4A3 is critical for cell growth of triple-negative breast cancer

被引:0
|
作者
den Hollander, Petra [1 ]
Tismelzon, Anna [2 ]
Shepherd, Jonathan [1 ]
Rawls, Kathryn R. [1 ]
Hill, Jamal L. [1 ]
Mazumdar, Abhijit [1 ]
Hilsenbeck, Susan G. [2 ]
Mills, Gordon B. [1 ]
Brown, Powel H. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
10.1158/1538-7445.AM2014-971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
971
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival
    den Hollander, Petra
    Rawls, Kathryn
    Tsimelzon, Anna
    Shepherd, Jonathan
    Mazumdar, Abhijit
    Hill, Jamal
    Fuqua, Suzanne A. W.
    Chang, Jenny C.
    Osborne, C. Kent
    Hilsenbeck, Susan G.
    Mills, Gordon B.
    Brown, Powel H.
    CANCER RESEARCH, 2016, 76 (07) : 1942 - 1953
  • [2] PTP4A3 is oncogenic and modulates triple negative breast cancer growth
    Gari, Hamid H.
    Ray, Rahul
    Lucia, Scott
    Porter, Christopher C.
    Gearheart, Christy M.
    Fosmire, Susan
    DeGala, Gregory D.
    Fan, Zeying
    Ru, Yuanbin
    Thor, Ann D.
    Lambert, James R.
    CANCER RESEARCH, 2014, 74 (19)
  • [3] The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth
    Qian, Jing
    Ma, Yanxia
    Tahaney, William M.
    Moyer, Cassandra L.
    Lanier, Amanda
    Hill, Jamal
    Coleman, Darian
    Koupaei, Negar
    Hilsenbeck, Susan G.
    Savage, Michelle I.
    Page, Brent D. G.
    Mazumdar, Abhijit
    Brown, Powel H.
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [4] Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth
    Jing Qian
    Yanxia Ma
    William M. Tahaney
    Cassandra L. Moyer
    Amanda Lanier
    Jamal Hill
    Darian Coleman
    Negar Koupaei
    Susan G. Hilsenbeck
    Michelle I. Savage
    Brent D. G. Page
    Abhijit Mazumdar
    Powel H. Brown
    Breast Cancer Research, 26
  • [5] SOX9 is a critical regulator of triple-negative breast cancer cell growth and invasion
    Ma, Y.
    Shepherd, J.
    Mazumdar, A.
    Zhao, D.
    Bollu, L.
    Hill, J.
    Zhang, Y.
    Brown, P.
    CANCER RESEARCH, 2017, 77
  • [6] Depletion of PTP4A3 phosphatase disrupts colorectal cancer cell adhesion and extracellular matrix interactions
    McQueeney, Kelley E.
    Pekic, Paula
    Salamoun, Joseph M.
    Ahn, Jennifer
    Sharlow, Elizabeth R.
    Wipf, Peter
    Lazo, John S.
    CANCER RESEARCH, 2016, 76
  • [7] Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents
    Sharlow, Elizabeth R.
    Wipf, Peter
    McQueeney, Kelley E.
    Bakan, Ahmet
    Lazo, John S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (05) : 661 - 673
  • [8] PTP4A3 phosphatase is a novel drug target for epithelial ovarian cancer.
    Cornelison, John Robert
    Rastelli, Ettore J.
    Hart, Duncan J.
    Mendelson, Anna J.
    Sharlow, Elizabeth R.
    Wipf, Peter
    Lazo, John S.
    CANCER RESEARCH, 2021, 81 (13)
  • [9] Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer
    Lazo, John S.
    Sharlow, Elizabeth R.
    Cornelison, Robert
    Hart, Duncan J.
    Llaneza, Danielle C.
    Mendelson, Anna J.
    Rastelli, Ettore J.
    Tasker, Nikhil R.
    Landen, Charles N., Jr.
    Wipf, Peter
    BIOMOLECULES, 2021, 11 (07)
  • [10] Discovering potent PTP4A3 phosphatase small molecule inhibitors for colorectal cancer
    McQueeney, Kelley E.
    Salamoun, Joseph M.
    Handing, Kasia
    Boulton, Adam
    Sharlow, Elizabeth R.
    Bushweller, John H.
    Minor, Wladek
    Wipf, Peter
    Lazo, John S.
    FASEB JOURNAL, 2016, 30